Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
COVID-19
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
COVID-19
Webinars

Skip Nav Destination

Issues

Select Year

Issue

Volume 14, Issue 19_Supplement

1 October 2008

ISSN 1078-0432

EISSN 1557-3265

In this Issue

Assay Validation
Clinical Trials
Detection of Circulating Tumor Cells and Plasma DNA
From Discovery to Product
Functional and Molecular Imaging in Vivo and in Vitro
Genomics and Expression Profiling
In Vitro and in Vivo Assays and Models
Integrating Biomarkers and Drug Development
Methylation Profiling, Epigenetics, and Chromatin Regulation
Molecular Classification and Prognostic Markers
Molecular Imaging: From Mouse to Human
Molecular Marker Driven Trial Design
Molecular Markers and Cancer Stem Cells
Molecular Markers and Treatment
Molecular Response Prediction Markers
Nanotechnology
Non-Coding RNAs
Non-coding RNAs
Noninvasive Markers
Novel Assay Technologies
Patient Selection/Stratification
Pharmacodynamics and Pharmacokinetics
Pharmacodynamics of Markers
Pharmacogenomics
Pharmacology, Pharmacogenetics, and Pharmacogenomics
Predictive Response Molecular Markers
Proteomics
Regulatory Issues and Science Policy
Signaling Pathways in Therapy Design and Response
Target Identification, Validation, Lead Discovery, and Optimization

Issue Category Search

AACR International Conference: Molecular Diagnostics in Cancer Therapeutic Development-- Sep 22-25, 2008; Philadelphia, PA

Assay Validation

Clinical Trials

Detection of Circulating Tumor Cells and Plasma DNA

From Discovery to Product

Functional and Molecular Imaging in Vivo and in Vitro

Genomics and Expression Profiling

In Vitro and in Vivo Assays and Models

Integrating Biomarkers and Drug Development

Methylation Profiling, Epigenetics, and Chromatin Regulation

Molecular Classification and Prognostic Markers

Molecular Imaging: From Mouse to Human

Molecular Marker Driven Trial Design

Molecular Markers and Cancer Stem Cells

Molecular Markers and Treatment

Molecular Response Prediction Markers

Nanotechnology

Non-Coding RNAs

Non-coding RNAs

Noninvasive Markers

Novel Assay Technologies

Patient Selection/Stratification

Pharmacodynamics and Pharmacokinetics

Pharmacodynamics of Markers

Pharmacogenomics

Pharmacology, Pharmacogenetics, and Pharmacogenomics

Predictive Response Molecular Markers

Proteomics

Regulatory Issues and Science Policy

Signaling Pathways in Therapy Design and Response

Target Identification, Validation, Lead Discovery, and Optimization

Advertisement

Email alerts

Online First Alert

eTOC Alert

Latest
Most Read
Most Cited

A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation

Phase I Trial of a Novel Anti-HER2 Antibody–Drug Conjugate, ARX788, for the Treatment of HER2-Positive Metastatic Breast Cancer

The Impact of PIK3R1 Mutations and Insulin–PI3K–Glycolytic Pathway Regulation in Prostate Cancer

Systemic and oligo-acquired resistance to PD-(L)1 blockade in lung cancer

Issues
Online First
Collections

News
Twitter

Online ISSN 1557-3265
Print ISSN 1078-0432

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers, & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Info for Advertisers
Info for Librarians
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2022 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept